Combination of Isosorbide Dinitrate and Hydralazine in Blacks with Heart Failure
The DOI matches its Crossref record, with a small difference in title or year; 61 of the 61 references it cites were found in a registry or an index.
Abstract
BACKGROUND: We examined whether a fixed dose of both isosorbide dinitrate and hydralazine provides additional benefit in blacks with advanced heart failure, a subgroup previously noted to have a favorable response to this therapy. METHODS: A total of 1050 black patients who had New York Heart Association class III or IV heart failure with dilated ventricles were randomly assigned to receive a fixed dose of isosorbide dinitrate plus hydralazine or placebo in addition to standard therapy for heart failure. The primary end point was a composite score made up of weighted values for death from any cause, a first hospitalization for heart failure, and change in the quality of life. RESULTS: The study was terminated early owing to a significantly higher mortality rate in the placebo group than in the group given isosorbide dinitrate plus hydralazine (10.2 percent vs. 6.2 percent, P=0.02). The mean primary composite score was significantly better in the group given isosorbide dinitrate plus hydralazine than in the placebo group (-0.1+/-1.9 vs. -0.5+/-2.0, P=0.01; range of possible values, -6 to +2), as were its individual components (43 percent reduction in the rate of death from any cause [hazard ratio, 0.57; P=0.01] 33 percent relative reduction in the rate of first hospitalization for heart failure [16.4 percent vs. 22.4 percent, P=0.001], and an improvement in the quality of life [change in score, -5.6+/-20.6 vs. -2.7+/-21.2, with lower scores indicating better quality of life; P=0.02; range of possible values, 0 to 105]). CONCLUSIONS: The addition of a fixed dose of isosorbide dinitrate plus hydralazine to standard therapy for heart failure including neurohormonal blockers is efficacious and increases survival among black patients with advanced heart failure.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The primary outcome was a weighted score, but individual components of the outcome showed a difference favouring H-ISDN for all-cause mortality, first HHF, and change in quality of life score.”
From CCS/CHFS Heart Failure Guidelines Update: Defining a New Pharmacologic Standard of Care for Heart Failure With Reduced Ejection Fraction (2021) · cites this paper as [79]
In the citing paper
“Digoxin may reduce the risk of HF hospitalization in patients with HFrEF treated with ACE-Is, irrespective of diabetes status.519”
From 2023 ESC guidelines for the management of cardiovascular disease in patients with diabetes. (2023) · cites this paper as [519]
Citations
Cites
Pfeffer, M. A., Braunwald, E., Moyé, L. A., Basta, L., Brown, E. J., Cuddy, T. E., Davis, B. R., Geltman, E. M., Goldman, S., Flaker, G. C., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199209033271001 · Cited by 5,911
Effects of Enalapril on Mortality in Severe Congestive Heart Failure
The Consensus Trial Study Group* (1987) · New England Journal of Medicine · doi:10.1056/nejm198706043162301 · Cited by 5,121
Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress
Cai, H., & Harrison, D. G. (2000) · Circulation Research · doi:10.1161/01.res.87.10.840 · Cited by 3,839
A Randomized Trial of the Angiotensin-Receptor Blocker Valsartan in Chronic Heart Failure
Cohn, J. N., & Tognoni, G. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa010713 · Cited by 3,108
Self-citationEffect of carvedilol on survival in severe chronic heart failure
Packer, M., Coats, A. J. S., Fowler, M. B., Katus, H. A., Krum, H., Mohacsi, P., Rouleau, J. L., Tendera, M., Castaigne, A., Roecker, E. B., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105313442201 · Cited by 3,093
Cohn, J. N., Johnson, G., Ziesche, S., Cobb, F., Francis, G., Tristani, F., Smith, R., Dunkman, W. B., Loeb, H., Wong, M., et al. (1991) · New England Journal of Medicine · doi:10.1056/nejm199108013250502 · Cited by 2,833
Self-citationSuperoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor
Gryglewski, R. J., Palmer, R. M. J., & Moncada, S. (1986) · Nature · doi:10.1038/320454a0 · Cited by 2,400
Effect of Vasodilator Therapy on Mortality in Chronic Congestive Heart Failure
Cohn, J. N., Archibald, D. G., Ziesche, S., Franciosa, J. A., Harston, W. E., Tristani, F. E., Dunkman, W. B., Jacobs, W., Francis, G. S., Flohr, K. H., et al. (1986) · New England Journal of Medicine · doi:10.1056/nejm198606123142404 · Cited by 2,400
Self-citationEffect of carvedilol on survival in severe chronic heart failure
Packer, M., Coats, A. J. S., & Fowler, M. B. (2001) · ACC Current Journal Review · doi:10.1016/s1062-1458(01)00477-9 · Cited by 1,661
Cellular and molecular mechanisms of endothelial cell dysfunction.
Harrison, D. G. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119751 · Cited by 1,053
Rector, T. S., & Cohn, J. N. (1992) · American Heart Journal · doi:10.1016/0002-8703(92)90986-6 · Cited by 1,018
Self-citationA Trial of the Beta-Blocker Bucindolol in Patients with Advanced Chronic Heart Failure
(2001) · New England Journal of Medicine · doi:10.1056/nejm200105313442202 · Cited by 1,007
Endothelium-dependent vasodilation is attenuated in patients with heart failure.
Kubo, S. H., Rector, T. S., Bank, A. J., Williams, R. E., & Heifetz, S. M. (1991) · Circulation · doi:10.1161/01.cir.84.4.1589 · Cited by 775
Modification of Sample Size in Group Sequential Clinical Trials
Cui, L., Hung, H. M. J., & Wang, S. (1999) · Biometrics · doi:10.1111/j.0006-341x.1999.00853.x · Cited by 574
Exner, D. V., Dries, D. L., Domanski, M. J., & Cohn, J. N. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105033441802 · Cited by 567
Self-citationKeith, M., Geranmayegan, A., Sole, M. J., Kurian, R., Robinson, A., Omran, A. S., & Jeejeebhoy, K. N. (1998) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(98)00101-6 · Cited by 556
Endothelial function in chronic congestive heart failure
Drexler, H., Hayoz, D., Münzel, T., Hornig, B., Just, H., Brunner, H. R., & Zelis, R. (1992) · The American Journal of Cardiology · doi:10.1016/0002-9149(92)90710-g · Cited by 550
Oxygen free radicals and congestive heart failure.
Belch, J. J., Bridges, A. B., Scott, N., & Chopra, M. (1991) · Heart · doi:10.1136/hrt.65.5.245 · Cited by 550
Identification of the enzymatic mechanism of nitroglycerin bioactivation
Chen, Z., Zhang, J., & Stamler, J. S. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.122225199 · Cited by 541
Carson, P., Ziesche, S., Johnson, G., & Cohn, J. N. (1999) · Journal of Cardiac Failure · doi:10.1016/s1071-9164(99)90001-5 · Cited by 533
Self-citationIgnarro, L. J., Napoli, C., & Loscalzo, J. (2002) · Circulation Research · doi:10.1161/hh0102.102330 · Cited by 491
Packer, M. (2001) · Journal of Cardiac Failure · doi:10.1054/jcaf.2001.25652 · Cited by 396
Racial Differences in the Outcome of Left Ventricular Dysfunction
Dries, D. L., Exner, D. V., Gersh, B. J., Cooper, H. A., Carson, P. E., & Domanski, M. J. (1999) · New England Journal of Medicine · doi:10.1056/nejm199902253400804 · Cited by 368
Self-citationKalinowski, L., Dobrucki, I. T., & Malinski, T. (2004) · Circulation · doi:10.1161/01.cir.0000129087.81352.7a · Cited by 326
Münzel, T., Kurz, S., Rajagopalan, S., Thoenes, M., Berrington, W. R., Thompson, J. A., Freeman, B. A., & Harrison, D. G. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118935 · Cited by 314
Scherrer-Crosbie, M., Ullrich, R., Bloch, K. D., Nakajima, H., Nasseri, B., Aretz, H. T., Lindsey, M. L., Vançon, A.-C., Huang, P. L., Lee, R. T., et al. (2001) · Circulation · doi:10.1161/hc3601.094298 · Cited by 310
Sydow, K., Daiber, A., Oelze, M., Chen, Z., August, M., Wendt, M., Ullrich, V., Mülsch, A., Schulz, E., Keaney, J. F., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200419267 · Cited by 300
Race and the Response to Adrenergic Blockade with Carvedilol in Patients with Chronic Heart Failure
Yancy, C. W., Fowler, M. B., Colucci, W. S., Gilbert, E. M., Bristow, M. R., Cohn, J. N., Lukas, M. A., Young, S. T., & Packer, M. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105033441803 · Cited by 288
Self-citationJanssens, S., Pokreisz, P., Schoonjans, L., Pellens, M., Vermeersch, P., Tjwa, M., Jans, P., Scherrer-Crosbie, M., Picard, M. H., Szelid, Z., et al. (2004) · Circulation Research · doi:10.1161/01.res.0000126497.38281.23 · Cited by 231
Endothelial nitric oxide synthase overexpression attenuates congestive heart failure in mice
Jones, S. P., Greer, J. J. M., van Haperen, R., Duncker, D. J., de Crom, R., & Lefer, D. J. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0837428100 · Cited by 229
Increased malondialdehyde in peripheral blood of patients with congestive heart failure
Díaz-Vélez, C. R., García-Castiñeiras, S., Mendoza-Ramos, E., & Hernández-López, E. (1996) · American Heart Journal · doi:10.1016/s0002-8703(96)90063-0 · Cited by 216
Length, force, and Ca(2+)-troponin C affinity in cardiac and slow skeletal muscle
Wang, Y. P., & Fuchs, F. (1994) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1994.266.4.c1077 · Cited by 206
Gillum, R. F. (1979) · Hypertension · doi:10.1161/01.hyp.1.5.468 · Cited by 203
Hare, J. M., Givertz, M. M., Creager, M. A., & Colucci, W. S. (1998) · Circulation · doi:10.1161/01.cir.97.2.161 · Cited by 163
Vasodilation in black Americans: Attenuated nitric oxide-mediated responses*
Stein, C., Lang, C. C., Nelson, R. A., Brown, M., & Wood, A. J. J. (1997) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(97)90122-3 · Cited by 162
Cardillo, C., Kilcoyne, C. M., Cannon, R. O., & Panza, J. A. (1998) · Hypertension · doi:10.1161/01.hyp.31.6.1235 · Cited by 152
A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure
Cohn, J. N., & Tognoni, G. (2002) · ACC Current Journal Review · doi:10.1016/s1062-1458(02)00651-7 · Cited by 149
Self-citationDefective endothelium-mediated control of coronary circulation in conscious dogs after heart failure
Wang, J., Seyedi, N., Xu, X. B., Wolin, M. S., & Hintze, T. H. (1994) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1994.266.2.h670 · Cited by 143
Gogia, H., Mehra, A., Parikh, S., Raman, M., Ajit-Uppal, J., Johnson, J. V., & Elkayam, U. (1995) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(95)00368-1 · Cited by 137
Heart failure in African Americans: A cardiovascular enigma
Yancy, C. W. (2000) · Journal of Cardiac Failure · doi:10.1054/jcaf.2000.17610 · Cited by 122
Self-citationLiu, Y.-H., Xu, J., Yang, X.-P., Yang, F., Shesely, E. G., & Carretero, O. A. (2002) · Hypertension · doi:10.1161/hy02t2.102796 · Cited by 119
Bauer, J. A., & Fung, H. L. (1991) · Circulation · doi:10.1161/01.cir.84.1.35 · Cited by 113
Nitric Oxide Modulates Mitochondrial Respiration in Failing Human Heart
Loke, K. E., Laycock, S. K., Mital, S. R., Wolin, M. S., Bernstein, R. D., Oz, M. C., Addonizio, L. J., Kaley, G., & Hintze, T. H. (1999) · Circulation · doi:10.1161/01.cir.100.12.1291 · Cited by 110
Dries, D. L., Strong, M. H., Cooper, R., & Drazner, M. H. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)01943-5 · Cited by 109
Dixon, L., Morgan, D. R., Hughes, S., McGrath, L. T., El-Sherbeeny, N. A., Plumb, R., Devine, A. B., Leahey, W. J., Johnston, G. D., & McVeigh, G. E. (2003) · Circulation · doi:10.1161/01.cir.0000066283.13253.78 · Cited by 107
African-American Heart Failure Trial (A-HeFT): Rationale, design, and methodology
Franciosa, J. A., Taylor, A. L., Cohn, J. N., Yancy, C. W., Ziesche, S., Olukotun, A. Y., Ofili, E., Ferdinand, K. C., Loscalzo, J., & Worcel, M. (2002) · Journal of Cardiac Failure · doi:10.1054/jcaf.2002.124730 · Cited by 107
Self-citationIncreased Superoxide in Heart Failure
Münzel, T. F., & Harrison, D. G. (1999) · Circulation · doi:10.1161/01.cir.100.3.216 · Cited by 105
Nonparametric Estimation of a Delay Distribution Based on Left‐Censored and Right‐Truncated Data
Cui, J. S. (1999) · Biometrics · doi:10.1111/j.0006-341x.1999.00345.x · Cited by 104
Nitric Oxide Synthases in the Failing Human Heart
Drexler, H. (1999) · Circulation · doi:10.1161/01.cir.99.23.2972 · Cited by 101
Effects of Black Race on Forearm Resistance Vessel Function
Kahn, D. F., Duffy, S. J., Tomasian, D., HOLBROOK, M. M., Rescorl, L., Russell, J. D., Gokce, N., Loscalzo, J., & Vita, J. A. (2002) · Hypertension · doi:10.1161/01.hyp.0000024571.69634.ed · Cited by 94
Mohri, M., Egashira, K., Tagawa, T., Kuga, T., Tagawa, H., Harasawa, Y., Shimokawa, H., & Takeshita, A. (1997) · Hypertension · doi:10.1161/01.hyp.30.1.50 · Cited by 76
Oxidative Stress and Endothelial Dysfunction in Heart Failure
Sharma, R., & Davidoff, M. N. (2002) · Congestive Heart Failure · doi:10.1111/j.1527-5299.2002.00714.x · Cited by 68
Information and information fractions for design and sequential monitoring of clinical trials
Lan, K. K. G., Reboussin, D. M., & DeMets, D. L. (1994) · Communication in Statistics- Theory and Methods · doi:10.1080/03610929408831263 · Cited by 66
Nitric Oxide Protects Against Pathological Ventricular Remodeling
Prabhu, S. D. (2004) · Circulation Research · doi:10.1161/01.res.0000129569.07667.89 · Cited by 62
Recchia, F. A., Osorio, J. C., Chandler, M. P., Xu, X., Panchal, A. R., Lopaschuk, G. D., Hintze, T. H., & Stanley, W. C. (2002) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2002.282.1.e197 · Cited by 58
Houghton, J. L., Smith, V. E., Strogatz, D. S., Henches, N. L., Breisblatt, W. M., & Carr, A. A. (1997) · Hypertension · doi:10.1161/01.hyp.29.3.706 · Cited by 56
Ethnic Differences in Forearm Vasodilator Capacity
Hinderliter, A. L., Sager, A. R., Sherwood, A., Light, K. C., Girdler, S. S., & Willis, P. W. (1996) · The American Journal of Cardiology · doi:10.1016/s0002-9149(96)90397-5 · Cited by 55
McVeigh, G. E., Hamilton, P., Wilson, M., Hanratty, C. G., Leahey, W. J., Devine, A. B., Morgan, D. G., Dixon, L., & McGrath, L. T. (2002) · Circulation · doi:10.1161/01.cir.0000021600.84149.78 · Cited by 47
Does race matter in heart failure?
Yancy, C. W. (2003) · American Heart Journal · doi:10.1016/s0002-8703(03)00241-2 · Cited by 30
Self-citationThe African-American heart failure trial (A-HeFT): rationale and methodology*1
TAYLOR, A. J. (2003) · Journal of Cardiac Failure · doi:10.1054/s1071-9164(03)00591-8 · Cited by 23
Self-citation
Cited by
McDonagh, T. A., Metra, M., Adamo, M., Gardner, R. S., Baumbach, A., Böhm, M., Burri, H., Butler, J., Čelutkienė, J., Chioncel, O., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab670 · Cited by 19,442
2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure
McDonagh, T. A., Metra, M., Adamo, M., Gardner, R. S., Baumbach, A., Böhm, M., Burri, H., Butler, J., Čelutkienė, J., Chioncel, O., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab368 · Cited by 13,344
2013 ACCF/AHA Guideline for the Management of Heart Failure
Yancy, C. W., Jessup, M., Bozkurt, B., Butler, J., Casey, D. E., Drazner, M. H., Fonarow, G. C., Geraci, S. A., Horwich, T., Januzzi, J. L., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.05.019 · Cited by 12,536
Self-citation2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
Ponikowski, P., Voors, A. A., Anker, S. D., Bueno, H., Cleland, J. G. F., Coats, A. J. S., Falk, V., González-Juanatey, J. R., Harjola, V.-P., Jankowska, E. A., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw128 · Cited by 11,429
Self-citation2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes
Knuuti, J., Wijns, W., Saraste, A., Capodanno, D., Barbato, E., Funck-Brentano, C., Prescott, E., Storey, R. F., Deaton, C., Cuisset, T., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehz425 · Cited by 7,166
Metadata
- Authors
- Taylor, A. L., Ziesche, S., Yancy, C., Carson, P., D'Agostino, R., Ferdinand, K., Taylor, M., Adams, K., Sabolinski, M., Worcel, M., & Cohn, J. N.
- Affiliations
- University of Minnesota (US)
- United States Department of Veterans Affairs (US)
- The University of Texas Southwestern Medical Center (US)
- Veterans Health Administration (US)
- Xavier University of Louisiana (US)
- Association of Black Cardiologists (US)
- University of North Carolina at Chapel Hill (US)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2004-11-11
- Volume
- 351
- Issue
- 20
- Pages
- 2049-2057
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2140023412
- Cited by
- 1,773
- References
- 61
- Citations by year
- 2026: 28 · 2025: 30 · 2024: 43 · 2023: 67 · 2022: 68 · 2021: 70 · 2020: 76 · 2019: 53 · 2018: 58 · 2017: 90 · 2016: 78 · 2015: 79 · 2014: 76 · 2013: 78 · 2012: 97
- FWCI
- 84.29
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Failure Treatment and Management
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart rate and cardiovascular health
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
- Keywords
- isosorbide dinitrate, hydralazine, advanced heart failure, Black patients, fixed-dose combination, mortality, heart failure hospitalization, quality of life, dilated ventricles
- MeSH terms
- Adult, Aged, Double-Blind Method, Drug Combinations, Drug Therapy, Combination, Female, Heart Failure, Humans, Hydralazine, Isosorbide Dinitrate, Male, Middle Aged, Quality of Life, Vasodilator Agents, Survival Analysis, Treatment Outcome, Nitric Oxide Donors, Black People
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.